In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Norox bzp-C-35 Drug Master File in Korea (Norox bzp-C-35 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Norox bzp-C-35. The MFDS reviews the Norox bzp-C-35 KDMF as part of the drug registration process and uses the information provided in the Norox bzp-C-35 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Norox bzp-C-35 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Norox bzp-C-35 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Norox bzp-C-35 suppliers with KDMF on PharmaCompass.